Subcortical volumetric changes in MDD have been purported to underlie the symptoms of MDD, however, the evidence to date remains inconsistent. Here, we investigated the relationship between structural limbic brain measurements and MDD symptomology through high-resolution segmentation of the amygdala and hippocampus. We report the novel finding that MDD severity is consistently negatively associated with amygdala nuclei, linking volumetric reductions with worsening depressive symptoms.
Structural MRI data was acquired for 24 unmedicated participants with a primary diagnosis of MDD and 20 matched controls on a 7T whole body scanner (Magnetom, Siemens Healthcare, Erlangen, Germany). A SC72CD gradient coil was used with a single coil transmit and a 32-channel head coil (Nova Medical, Wilmington, MA, USA). A T1-weighted MP2RAGE sequence and a coronal-oblique T2-weighted turbo spin echo (T2-TSE) sequence were obtained for all participants.
Image reconstruction and automated segmentation of the whole amygdala into subnuclei and the whole hippocampus into subfields was carried out in FreeSurfer (http://surfer.nmr.mgh.harvard.edu) v6.0. Both T1- and T2-weighted images were utilized to maximize accuracy of the segmentation process. The amygdala was segmented into the lateral, basal, accessory basal, cortical, medial and central nuclei and the corticoamygdaloid transition area (Fig.1). The superficial structures and the deep structures were also investigated as the centrocortical complex (central, medial and cortical nuclei) and the basolateral complex (basal, lateral and accessory basal nuclei) respectively. The hippocampus was segmented into the subiculum, presubiculum, parasubiculum, CA1, CA3, CA4, the granule cell layer of the dentate gyrus, the molecular layer of the dentate gyrus, the hippocampal-amygdala transition area and the fimbria. Subfields were combined into CA1, CA3/4, the subicular complex (pre-, para- and subiculum) and the dentate gyrus (granule cell layer and molecular layer) to ensure subfield structures were large enough for accurate volume quantification (Fig. 2). Additionally, all participants completed the Montgomery-Asberg Depression Rating Scale (MADRS; higher score indicates greater depression severity) to quantify depressive symptomology.
NIH RO1 MH109544
NIH R01 CA202911
NARSAD Young Investigator Grant
Icahn School of Medicine Capital Campaign, Translational and Molecular Imaging
Institute and Department of Radiology, Icahn School of Medicine at Mount Sinai, Siemens Healthcare
1 VAN EIJNDHOVEN, P. et al. Amygdala volume marks the acute state in the early course of depression. Biol Psychiatry, v. 65, n. 9, p. 812-8, May 1 2009. ISSN 1873-2402 (Electronic)0006-3223 (Linking). Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/19028381>.
2 FRODL, T. et al. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol Psychiatry, v. 53, n. 4, p. 338-44, Feb 15 2003. ISSN 0006-3223 (Print)0006-3223 (Linking). Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/12586453>.
3 TANG, Y. et al. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: A voxel-based morphometric magnetic resonance imaging study. Psychiatry Res,v. 156, n. 1, p. 83-6, Oct 15 2007. ISSN 0165-1781 (Print)0165-1781 (Linking). Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/17825533>.
4 CAMPBELL, S. et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry, v. 161, n. 4, p. 598-607, Apr 2004. ISSN 0002-953X (Print)0002-953X (Linking). Disponível em: < https://www.ncbi.nlm.nih.gov/pubmed/15056502>.